19th Oct 2007 11:09
Skyepharma PLC19 October 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing SKYEPHARMA PLC shares to which voting rights are attached: 2. Reason for the notification (please tick the appropriate box or boxes) An acquisition or disposal of voting rights x An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An event changing the breakdown of voting rights Other (please specify):___________________________________________ 3. Full name of person(s) subject to the notification The Goldman Sachs Group, Inc. obligation: 4. Full name of shareholder(s) (if different from 3.): Goldman, Sachs & Co. 5. Date of the transaction (and date on which the threshold is 16 OCTOBER 2007 crossed or reached if different): 6. Date on which issuer notified: 18 OCTOBER 2007 7. Threshold(s) that is/are crossed or reached: 3% 8. Notified details: A: Voting rights attached to shares Class/type of Situation previous to Resulting situation after the triggering transaction shares the Triggering transaction if possible Number of Number of Number of Number of voting rights % of voting rightsusing the ISIN Shares Voting shares ix CODE Rights viii Direct Direct x Indirect xi Direct Indirect GB0008123571 Below 3% 14 25,229,670 0.000% 3.096% US8308081012 Below 3% 7,730 0.001% (773 ADRs) B: Financial InstrumentsResulting situation after the triggering transaction xii Type of financial Expiration date Exercise/ Conversion Number of voting rights % of votinginstrument xiii Period/ Date xiv that may be acquired if rights the instrument is exercised/ converted. Total (A+B)Number of voting rights % of voting rights 25,237,414 3.09% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable xv: The interest in 25,229,670 shares arose from an interest held by Goldman, Sachs & Co., a wholly-owned direct subsidiary of GS Inc, acting as custodian for its customers. These shares are, or will be, registered in the name of Goldman Sachs Securities (Nominees), Limited. The interest in 14 shares arose from a beneficial interest held by Goldman Sachs International, a wholly-owned indirect subsidiary of GS Inc. These shares are, or will be, registered at CREST in account CREPTEMP. The interest in 7,730 shares arose from an interest held by Goldman, Sachs & Co., a wholly-owned direct subsidiary of GS Inc, acting as custodian for its customers of 773 American Depositary Receipts ("ADRs"). These ADRs are, or will be, held at the Depositary Trust Company of New York ("DTC"). Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: 14. Contact name: John Murphy 15. Contact telephone number: 020 7491 1777 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
SKP.L